SARS ‐ C o V ‐2‐derived protein Orf9b enhances MARK 2 activity via interaction with the autoinhibitory KA 1 domain
FEBS Letters · 2024
DOI: 10.1002/1873-3468.14975 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, 2024. Verfasst von Daiki Homma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, Japan. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, SARS-CoV-2, Protein Binding. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tokyo Metropolitan University, Takeda Foundation.
Abstract (Originalsprache)
Microtubule affinity‐regulating kinase 2 (MARK2) is a Ser/Thr protein kinase that regulates cell polarity and immune responses. Here, we report that Orf9b, one of the accessory proteins encoded in the SARS‐CoV‐2 genome, increases MARK2 activity via interaction with the autoinhibitory KAI domain. We found that co‐expression of Orf9b enhances the kinase activity of MARK2 in HEK293 cells. Orf9b does not bind to or enhance the activity of the mutant form of MARK2 lacking the KA1 domain. Orf9b lowers inhibitory phosphorylation of MARK2 at T595 while mutation experiments indicate that this site is dispensable for Orf9b‐mediated enhancement of MARK2 activity. Our results suggest that Orf9b enhances MARK2 activity by binding the autoinhibitory KA1 domain, which closely interacts with the kinase domain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, Japan.
- Department of Biological Sciences, School of Science, Tokyo Metropolitan University, Japan.
ORCID-Profile: Kanae Ando
Förderung
- Tokyo Metropolitan University
- Takeda Foundation
Zitieren
APA
Homma, D., Limlingan, S. J. M., Saito, T., & Ando, K. (2024). SARS ‐ C o V ‐2‐derived protein Orf9b enhances MARK 2 activity via interaction with the autoinhibitory KA 1 domain. FEBS Letters. https://doi.org/10.1002/1873-3468.14975
Vancouver
Homma D, Limlingan SJM, Saito T, Ando K. SARS ‐ C o V ‐2‐derived protein Orf9b enhances MARK 2 activity via interaction with the autoinhibitory KA 1 domain. FEBS Letters. 2024. doi:10.1002/1873-3468.14975
BibTeX
@article{Homma2024,
author = {Homma, Daiki and Limlingan, Sophia Jobien M and Saito, Taro and Ando, Kanae},
title = {SARS ‐ C o V ‐2‐derived protein Orf9b enhances MARK 2 activity via interaction with the autoinhibitory KA 1 domain},
journal = {FEBS Letters},
year = {2024},
doi = {10.1002/1873-3468.14975}
}
EUVIMED